rosiglitazone has been researched along with urea in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dülger, GA; Gedik, N; Sehirli, AO; Sener, G | 1 |
| den Ouden, K; Goldschmeding, R; Joles, JA; Nguyen, TQ; Verhaar, MC; Westerweel, PE | 1 |
| Binfaré, RW; García, AG; Kaster, MP; López, MG; Martín-Aparicio, E; Martinez, A; Medina, M; Morales, S; Navarro-Rico, ML; Rodrigues, AL; Rosa, AO | 1 |
| Brdar, I; Deng, X; Faessler, R; Mani, NS; Roessler, A; Sales, ZS; Wu, J | 1 |
| Gunness, P; Heinzle, E; Ingelman-Sundberg, M; Mueller, D; Noor, F; Shevchenko, V | 1 |
| Czechowska, G; Dudka, J; Korolczuk, A; Maciejewski, M; Smolen, A; Widelska, I | 1 |
| Feng, J; Li, H; Wang, Q; Xu, J; Zhang, Y; Zhao, S | 1 |
| Feng, J; Gao, X; Li, J; Li, W; Li, Z; Lu, M; Meng, P; Zhang, Y | 1 |
| Chen, E; Huang, J; Wu, J; Zheng, X | 1 |
1 trial(s) available for rosiglitazone and urea
| Article | Year |
|---|---|
Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPAR
Topics: Acute Kidney Injury; Animals; Caspase 3; Creatinine; Furosemide; Interleukin-10; Iohexol; Kidney; Nitrogen; NLR Family, Pyrin Domain-Containing 3 Protein; PPAR gamma; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rosiglitazone; Signal Transduction; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Urea | 2022 |
9 other study(ies) available for rosiglitazone and urea
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Rosiglitazone, a PPAR-gamma ligand, protects against burn-induced oxidative injury of remote organs.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Burns; Female; Hypoglycemic Agents; Interleukin-1beta; Kidney Diseases; L-Lactate Dehydrogenase; Liver Diseases; Male; Malondialdehyde; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Urea | 2007 |
Amelioration of anti-Thy1-glomerulonephritis by PPAR-gamma agonism without increase of endothelial progenitor cell homing.
Topics: Aneurysm; Animals; Blood Pressure; Bone Marrow Transplantation; Cell Movement; Disease Models, Animal; Endothelial Cells; Extracellular Matrix; Fibronectins; Gene Expression; Glomerulonephritis, Membranous; Hypoglycemic Agents; Isoantibodies; Kidney Cortex; Kidney Glomerulus; Male; Membrane Proteins; Plasminogen Activator Inhibitor 1; PPAR gamma; Proteinuria; Rats; Rats, Inbred BN; Rosiglitazone; Stem Cells; Thiazolidinediones; Transforming Growth Factor beta; Urea | 2008 |
Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.
Topics: Animals; Antidepressive Agents; Cyclic AMP-Dependent Protein Kinases; Cyclin-Dependent Kinase 5; Enzyme Inhibitors; Female; Glycogen Synthase Kinase 3; Male; Mice; Mitogen-Activated Protein Kinases; Motor Activity; PPAR gamma; Rosiglitazone; Swimming; Thiazoles; Thiazolidinediones; Urea | 2008 |
Direct, metal-free amination of heterocyclic amides/ureas with NH-heterocycles and N-substituted anilines in POCl3.
Topics: Amides; Amination; Aniline Compounds; Anticholesteremic Agents; Azabicyclo Compounds; Benzamides; Catalysis; Chemistry, Pharmaceutical; Erlotinib Hydrochloride; Eszopiclone; Fluorobenzenes; Heterocyclic Compounds; Humans; Hydrogen-Ion Concentration; Hypnotics and Sedatives; Hypoglycemic Agents; Imatinib Mesylate; Molecular Structure; Phosphorus Compounds; Piperazines; Prescription Drugs; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Rosiglitazone; Rosuvastatin Calcium; Sulfonamides; Thiazolidinediones; Urea | 2011 |
3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies.
Topics: Acetaminophen; Albumins; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Cell Culture Techniques; Cell Line, Tumor; Chromans; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Hepatocytes; High-Throughput Screening Assays; Humans; Liver; Multidrug Resistance-Associated Protein 2; Rosiglitazone; Spheroids, Cellular; Thiazolidinediones; Toxicity Tests, Acute; Troglitazone; Urea | 2013 |
The role of peroxisome-proliferator-activating receptor gamma agonists: rosiglitazone and 15-deoxy-delta12,14-prostaglandin J2 in chronic experimental cyclosporine A-induced nephrotoxicity.
Topics: Animals; Creatinine; Cyclosporine; Disease Models, Animal; Glutathione; Glutathione Disulfide; Kidney; Kidney Diseases; Male; NAD; NADP; PPAR gamma; Prostaglandin D2; Protective Agents; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Urea; Uric Acid | 2014 |
PPAR-γ agonist rosiglitazone ameliorates peritoneal deterioration in peritoneal dialysis rats with LPS-induced peritonitis through up-regulation of AQP-1 and ZO-1.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aquaporin 1; Gene Expression Regulation; Hemodialysis Solutions; Lipopolysaccharides; Male; Peritoneal Dialysis; Peritoneum; Peritonitis; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Urea; Zonula Occludens-1 Protein | 2018 |
PPARγ alleviates peritoneal fibrosis progression along with promoting GLUT1 expression and suppressing peritoneal mesothelial cell proliferation.
Topics: Animals; Cell Proliferation; Creatinine; Dialysis Solutions; Glucose; Glucose Transporter Type 1; Nitrogen; Peritoneal Fibrosis; PPAR gamma; Prostaglandin D2; Rats; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta; Urea | 2022 |